SEC Filing Summary: Eyenovia, Inc. (EYEN)
Business Context and Reporting Period
This Form 8-K was filed by Eyenovia, Inc. (not Hyperion Defi, Inc.) on July 5, 2024, reporting an event that occurred on July 2, 2024. The company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol "EYEN".
Key Financial Metrics
This filing is a current report regarding listing status and does not contain financial statements. Consequently, data on revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
The primary material event is a notification from Nasdaq staff that the Company's common stock closing bid price remained below the minimum $1.00 per share requirement for 30 consecutive business days prior to July 2, 2024, violating Nasdaq Listing Rule 5550(a)(2).
Outlook, Risks, and Contingencies
- Compliance Period: The Company has been granted an initial 180-day compliance period ending December 30, 2024, to regain compliance.
- Remediation Requirement: To cure the deficiency, the closing bid price must be $1.00 or more for at least 10 consecutive business days before the deadline.
- Secondary Compliance: If the initial period fails, the Company may be eligible for an additional 180-day period, contingent on meeting market value of publicly held shares and other initial listing standards.
- Delisting Risk: Failure to cure the deficiency or meet secondary standards may result in delisting. The Company may appeal a delisting determination, but there is no assurance of success.
- Management Action: Management intends to actively monitor the bid price and consider available options to regain compliance.
Investor Verification Checklist
- Verify the current trading price of EYEN to assess proximity to the $1.00 threshold.
- Review the Company's most recent 10-Q or 10-K for financial health and cash runway, as this 8-K contains no financial data.
- Monitor future press releases for announcements of reverse stock splits or other capital actions intended to raise the share price.
- Check for any subsequent Nasdaq correspondence regarding the status of the compliance period.